Article

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

2021-12-14

Abstract excerpt

The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections in various countries. This new variant of concern carries an unusually high number of mutations in key epitopes of neutralizing antibodies on the spike glycoprotein, suggesting potential immune evasion. Here we assessed serum neutralizing capacity in longitudinal cohorts of vaccinated and convalescent individuals, as well as monoclonal ant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56b8da2a-1422-5514-aa76-4523150a01ad
DOI: 10.1101/2021.12.14.21267769

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantDOI 10.1101/2021.12.14.21267769Read

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantSemantic proximity Read

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity Read

mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron VariantSemantic proximity Read

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantSemantic proximity Read

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesSemantic proximity Read

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity Read

Plasma neutralization properties of the SARS-CoV-2 Omicron variantSemantic proximity Read

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron VariantSemantic proximity Read

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.Semantic proximity Read

Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccinesSemantic proximity Read

Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3 <sup>rd</sup> mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adultsSemantic proximity Read

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantSemantic proximity Read